Published • loading... • Updated
Lmu Spin-Off Amplifold Achieves New Financing for the Development of Better Rapid Tests
Summary by bionity.com
2 Articles
2 Articles
Reposted by
bionity.com
Amplifold GmbH, a spin-off from LMU, has completed a seed financing round of five million euros. The start-up is developing a technology that uses DNA origami nanostructures to significantly increase the sensitivity of commercial lateral flow tests (LFAs).
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium